BIO-TECHNE Corp — Director's Dealing 2022

Aug 17, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIO-TECHNE Corp (TECH)
CIK: 0000842023
Period of Report: 2022-08-15

Reporting Person: Geist William (N/A)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-08-15	Restricted Stock Units	$	A	1785	Acquired		Common Stock (1785)	Direct
2022-08-15	Stock Options (Right to Buy)	$378.08	A	5550	Acquired	2029-08-15	Common Stock (5550)	Direct
2022-08-15	Stock Options (Right to Buy)	$378.08	A	7400	Acquired	2029-08-15	Common Stock (7400)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	2490	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Restricted Stock Units	$		Common Stock (840)	840	Direct
Stock Options (Right to Buy)	$401.57	2029-02-01	Common Stock (2984)	2984	Direct
Stock Options (Right to Buy)	$401.57	2029-02-01	Common Stock (3978)	3978	Direct

Footnotes

F1: Represents 2,490 shares of restricted stock for which the risk of forfeiture will lapse as to 830 shares on each of February 1, 2023, February 1, 2024 and February 1, 2025.

F2: Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock.

F3: Vests in full or in part on 8/15/2025 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).

F4: Options to purchase 1,850 shares vest on each of 8/15/2023, 8/15/2024, 8/51/2025 and 8/15/2026.

F5: Options to purchase 995 shares vest on each of 2/1/2023 and 2/1/2024 and options to purchase 994 shares vest on each of 2/1/2025 and 2/1/2026.